Building on the momentum of its recent in-person and virtual events, the Mary Kay O’Connor Process Safety Center (MKOPSC) at ...
At AHA 2024, the safety of GLP-1R agonists in heart failure and chronic kidney disease (CKD) patients was discussed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback